Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification

Journal of Clinical Microbiology

Volumn 36, Issue 5, 1998, Pages 1341-1346

  Blok, Marinus J ^a   Goossens, Valere J ^a   Vanherle, Sabina J V ^a   Top, Bert ^b   Tacken, Nicole ^b   Middeldorp, Jaap M ^b   Christiaans, Maarten H L ^a   Van Hooff, Johannes P ^a   Bruggeman, Cathrien A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Organon Teknika   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; MESSENGER RNA; PREDNISOLONE; TACROLIMUS; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; LEUKOCYTE CULTURE; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; SEROLOGY; VIRUS CULTURE; VIRUS ISOLATION;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0031959048     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.5.1341-1346.1998     Document Type: Article

References (30)

1. Bitsch, A., H. Kirchner, R. Dupke, and G. Bein. 1993. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. J. Infect. Dis. 167:740-743.
2. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
3. Compton, J. 1991. Nucleic acid sequence-based amplification. Nature 350: 91-92.
4. Davis, M. G., and E.-S. Huang. 1985. Nucleotide sequence of a human cytomegalovirus DNA fragment encoding a 67-kilodalton phosphorylated viral protein. J. Virol. 56:7-11.
5. Davis, M. G., E.-C. Mar, Y.-M. Wu, and E.-S. Huang. 1984. Mapping and expression of a human cytomegalovirus major viral protein. J. Virol. 52:129-135.
6. Gozlan, J., J. P. Laporte, S. Lesage, M. Labopin, A. Najman, N. C. Gorin, and J. C. Petit. 1996. Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J. Clin. Microbiol. 34:2085-2088.
7. Griffiths, P. D., S. Stagno, R. F. Pass, R. J. Smith, and C. A. Alford, Jr. 1982. Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J. Infect. Dis. 145:647-653.
8. Griffiths, P. D., P. R. Stirk, M. Ganczakowski, D. D. Panjwani, M. G. Ball, H. A. Blacklock, and H. G. Prentice. 1984. Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet ii:1242-1244.
9. Ho, M. 1994. Advances in understanding cytomegalovirus infection after transplantation. Transplant. Proc. 26:7-11.
10. Kievits, T., B. van Gemen, D. van Strijp, R. Schukkink, M. Dircks, H. Adriaanse, L. Malek, R. Sooknanan, and P. Lens. 1991. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods 35:273-286.
11. Kraat, Y. J., M. H. L. Christiaans, F. H. M. Nieman, P. M. van de Berg, J. P. van Hooff, and C. A. Bruggeman. 1994. Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy. Transplant International 7:362-367.
12. Kraat, Y. J., F. S. Stals, M. H. Christiaans, T. Lazzarotto, M. P. Landini, and C. A. Bruggeman. 1996. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients. J. Med. Virol. 48:289-294.
13. Landini, M. P., G. Mirolo, P. Coppolecchia, M. C. Re, and M. La Placa. 1986. Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiol. Immunol. 30:683-695.
14. Matthews, T., and R. Boehme. 1988. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10(Suppl. 3):S490-S494.
15. Metselaar, H. J. 1990. Diagnosis and prevention of cytomegalovirus infection after organ transplantation. Ph.D. thesis. University of Rotterdam, Rotterdam, The Netherlands.
16. Meyer-Köning, U., A. Serr, D. von Laer, G. Kirste, C. Wolff, O. Haller, D. Neumann Haefelin, and F. T. Hufert. 1995. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients. J. Infect. Dis. 171:705-709.
17. Miller, M. J., S. Bovey, K. Pado, D. A. Bruckner, and E. A. Wagar. 1994. Application of PCR to multiple specimen types for diagnosis of cytomegalovirus infection: comparison with cell culture and shell vial assay. J. Clin. Microbiol. 32:5-10.
18. Morré, S. A., P. Sillekens, M. V. Jacobs, P. van Aarle, S. de Blok, B. van Gemen, J. M. Walboomers, C. J. Meijer, and A. J. van den Bruit. 1996. RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J. Clin. Microbiol. 34:3108-3114.
19. Muesing, M. A., D. H. Smith, C. D. Cabradilla, C. V. Benton, L. A. Lasky, and D. J. Capon. 1995. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (London) 313:450-458.
20. Oldenburg, N., K. M. C. Lam, B. Top, M. A. Khan, N. Tacken, G. W. Mikhail, N. R. Banner, and M. Yacoub. 1997. A novel strategy to monitor CMV immediate early and iate gene expression as prognostic markers of CMV disease in thoracic organ transplant recipients using NASBA, abstr. 58, p. A-29. In Program and abstracts of the 6th International Cytomegalovirus Workshop.
21. Patel, R., T. F. Smith, M. Espy, D. Portela, R. H. Wiesner, R. A. Krom, and C. V. Paya. 1995. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J. Infect. Dis. 171:1010-1014.
22. Patel, R., D. R. Snydman, R. H. Rubin, M. Ho, M. Pescovitz, M. Martin, and C. V. Paya. 1996. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 61:1279-1289.
23. Rasmussen, L., D. Kelsall, R. Nelson, W. Carney, M. Hirsch, D. Winston, J. Preisaitis, and T. C. Merican. 1982. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J. Infect. Dis. 145:191-199.
24. Roseff, S. D., M. Rockis, J. F. Keiser, M. M. Caparas, J. Comerford, R. L. Sandin, and C. T. Garrett. 1993. Optimization for detection of cytomegalovirus by the polymerase chain reaction (PCR) in clinical samples. J. Virol. Methods 42:137-146.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
26. The, T. H., W. Van der Bij, A. P. Van den Berg, M. Van der Giessen, J. Weits, H. G. Sprenger, and W. J. Van Son. 1990. Cytomegalovirus antigenemia. Rev. Infect. Dis. 12:S737-S744.
27. The, T. H., M. van der Ploeg, A. P. van den Berg, A. M. Vlieger, M. van der Giessen, and W. J. van Son. 1992. Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction. Transplantation 54:193-198.
28. Van den Berg, A. P., W. Ven der Bij, W. J. Van Son, J. Anema, M. Van der Giessen, J. Schirm, A. M. Tegzess, and T. H. The. 1989. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - a report of 130 consecutive patients. Transplantation 48:991-995.
29. Van der Bij, W., J. Schirm, R. Torensma, W. J. van Son, A. M. Tegzess, and T. H. The. 1988. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J. Clin. Microbiol. 26:2531-2535.
30. Van Gemen, B., R. van Beuningen, A. Nabbe, D. van Strijp, S. Jurriaans, P. Lens, and T. Kievits. 1994. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J. Virol. Methods 49:157-167.